HLA-G
関連文献

“Beyond the increasing complexity of the immunomodulatory HLA-G molecule”. Blood 111 (10):  4862–4870. (May 2008). doi:10.1182/blood-2007-12-127662. PMID 18334671.
“HLA-G: from biology to clinical benefits”. Trends in Immunology 29 (3):  125–132. (March 2008). doi:10.1016/j.it.2007.11.005. PMID 18249584.
“Primate Mhc-E and -G alleles”. Immunogenetics 46 (4):  251–266. (1997). doi:10.1007/s002510050271. PMID 9218527.
“HLA-G in the human placenta: expression and potential functions”. Biochemical Society Transactions 28 (2):  208–212. (February 2000). doi:10.1042/bst0280208. PMID 10816129.
“Structure--function relationships in HIV-1 Nef”. EMBO Reports 2 (7):  580–585. (July 2001). doi:10.1093/embo-reports/kve141. PMC 1083955. PMID 11463741. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1083955/.
“Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G?”. Biology of Reproduction 67 (5):  1367–1374. (November 2002). doi:10.1095/biolreprod.102.005587. PMID 12390864.
“Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface”. Biology of Reproduction 67 (5):  1375–1378. (November 2002). doi:10.1095/biolreprod.102.005439. PMID 12390865.
“HLA-G protein processing and transport to the cell surface”. Cellular and Molecular Life Sciences 59 (9):  1460–1466. (September 2002). doi:10.1007/s00018-002-8521-8. PMID 12440768.
“HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication”. Journal of Biosciences 28 (3):  323–335. (April 2003). doi:10.1007/BF02970151. PMID 12734410.
“[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]”. Médecine/Sciences 19 (1):  100–106. (January 2003). doi:10.1051/medsci/2003191100. PMID 12836198.
“Soluble HLA-G1 at the materno-foetal interface--a review”. Placenta 24 (Suppl A):  S10–S15. (April 2003). doi:10.1053/plac.2002.0931. PMID 12842408.
“Role of CD1d-restricted NKT cells in microbial immunity”. Infection and Immunity 71 (10):  5447–5455. (October 2003). doi:10.1128/IAI.71.10.5447-5455.2003. PMC 201095. PMID 14500461. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201095/.
“Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathies”. Human Immunology 64 (11):  1050–1056. (November 2003). doi:10.1016/j.humimm.2003.07.001. PMID 14602235.
“HLA-G in skin cancer: a wolf in sheep's clothing?”. Human Immunology 64 (11):  1073–1080. (November 2003). doi:10.1016/j.humimm.2003.08.351. PMID 14602238.
Carosella ED; Moreau P; Le Maoult J et al. (2004). HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Advances in Immunology. 81. 199–252. doi:10.1016/S0065-2776(03)81006-4. ISBN 978-0-12-022481-4. PMID 14711057
“Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm”. Current Protein & Peptide Science 5 (1):  1–8. (February 2004). doi:10.2174/1389203043486955. PMID 14965316.
“[HLA-G in organ transplantation]”. Pathologie-Biologie 52 (2):  97–103. (March 2004). doi:10.1016/j.patbio.2003.04.006. PMID 15001239.
“HIV/SIV escape from immune surveillance: focus on Nef”. Current HIV Research 2 (2):  141–151. (April 2004). doi:10.2174/1570162043484924. PMID 15078178.
“Nef: "necessary and enforcing factor" in HIV infection”. Current HIV Research 3 (1):  87–94. (January 2005). doi:10.2174/1570162052773013. PMID 15638726.
“Antigen presenting cells and HLA-G--a review”. Placenta 26 (Suppl A):  S104–S109. (April 2005). doi:10.1016/j.placenta.2005.01.006. PMID 15837058.
“HIV accessory proteins and surviving the host cell”. Current HIV/AIDS Reports 1 (1):  47–53. (April 2004). doi:10.1007/s11904-004-0007-x. PMID 16091223.